Stay updated with breaking news from கோரிண்ணே லெ காஃப். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator Good morning. My name is Dee Tamara, and I will be your operator today. Welcome to Moderna s first-quarter earnings call. [Operator instructions] Please be advised that the call is being recorded. At this time, I d like to turn the call over to Lavina Talukdar, head, investor relations at Moderna. Please proceed. Lavina Talukdar Head of Investor Relations Thank you, Dee Tamara. Good morning, everyone. Thank you for joining us on today s call to discuss Moderna s first-quarter 2021 financial results and business updates. You can access the press release issued this morning, as well as the slides that we ll be reviewing by going to the investors section of our website. ....
03 May 2021 / 13:56 H. FILE PHOTO: Vials of the Moderna Covid-19 vaccine are seen at Apotex pharmaceutical company as Humber River Hospital’s mobile vaccine clinic vaccinate employees as part of the coronavirus disease (Covid-19) vaccination campaign, in Toronto, Ontario, Canada April 13, 2021. - Reuters KUALA LUMPUR: Zuellig Pharma, a leading healthcare services provider in Asia and Moderna, Inc.. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines announced a new partnership with Zuellig Pharma’s division, ZP Therapeutics, to supply the Covid-19 Vaccine Moderna in Southeast Asia, Hong Kong, Macau and Taiwan. “Our collaboration with Moderna to supply the Covid-19 Vaccine Moderna in Asia reaffirms Zuellig Pharma’s commitment to help fight the global pandemic. We are committed to making healthcare accessible through innovation, commercial excellence and robust in-market capabilities that will not only improve healthcare but ....
The United States has officially distributed more than 200 million Covid vaccines; globally, more than a billion doses have been administered. This rollout is a testament to science and human determination and particularly the determination of women who happen to be over the age of 50. ....
https://www.afinalwarning.com/514483.html (Natural News) Robert Verkerk, a Britain-based multi-disciplinary scientist who received his doctorate from Selective pressure is any cause that increases or reduces an organism’s chances of survival and reproductive success, depending on his or her traits. It drives natural selection, the process in which organisms that are better adapted to their environment tend to survive and produce more offspring. Verkerk, who is the founder of the advocacy group Alliance for Natural Health International, opines that the selection pressure from the most intensive vaccination programs, coupled with widespread infections and the impact of lockdowns and other restrictions, provides the perfect breeding ground for “immune escape” variants. These are viruses that are resistant to the protection provided by a vaccine or a recent infection. ....
https://www.afinalwarning.com/512192.html (Natural News) Two shots may not be enough for those who received the Pfizer-BioNTech and Moderna coronavirus (COVID-19) vaccines. Pfizer CEO Albert Bourla said people who’ve gotten both doses of the Pfizer-BioNTech jab would likely need a third shot within 12 months and might need an annual shot thereafter. “There are vaccines … like polio that one dose is enough, there are vaccines like pneumococcal vaccine that one dose is enough for adults, and there are vaccines like flu that you need every year,” Bourla said. “The COVID virus looks more like the influenza virus than the polio virus.” ....